View in EDS

Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?

Saved in:
Bibliographic Details
Title: Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
Authors: Backes, F.1, Richardson, D.2, McCann, G.1, Salani, R.1, Eisenhauer, E.1, Fowler, J.1, Copeland, L.1, Cohn, D.1, O'Malley, D.1
Source: Gynecologic Oncology. Mar2012 Supplement, Vol. 125, pS94-S94. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 73498517
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Backes%2C+F%2E%22">Backes, F.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Richardson%2C+D%2E%22">Richardson, D.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22McCann%2C+G%2E%22">McCann, G.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Salani%2C+R%2E%22">Salani, R.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Eisenhauer%2C+E%2E%22">Eisenhauer, E.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Fowler%2C+J%2E%22">Fowler, J.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Copeland%2C+L%2E%22">Copeland, L.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Cohn%2C+D%2E%22">Cohn, D.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22O'Malley%2C+D%2E%22">O'Malley, D.</searchLink><relatesTo>1</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. Mar2012 Supplement, Vol. 125, pS94-S94. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=73498517
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ygyno.2011.12.226
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S94
    Titles:
      – TitleFull: Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Backes, F.
      – PersonEntity:
          Name:
            NameFull: Richardson, D.
      – PersonEntity:
          Name:
            NameFull: McCann, G.
      – PersonEntity:
          Name:
            NameFull: Salani, R.
      – PersonEntity:
          Name:
            NameFull: Eisenhauer, E.
      – PersonEntity:
          Name:
            NameFull: Fowler, J.
      – PersonEntity:
          Name:
            NameFull: Copeland, L.
      – PersonEntity:
          Name:
            NameFull: Cohn, D.
      – PersonEntity:
          Name:
            NameFull: O'Malley, D.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 03
              Text: Mar2012 Supplement
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-print
              Value: 00908258
          Numbering:
            – Type: volume
              Value: 125
          Titles:
            – TitleFull: Gynecologic Oncology
              Type: main
ResultId 1